Frontotemporal Dementia - Symptoms, Causes, Treatment & Prevention

Worldwide prevalence estimates range from **15 to 22 cases per 100,000 people**; in the United States, approximately **20,000‑30,000 new cases are diagnosed each year**.^[2]

Symptoms

Symptoms differ by variant, but they all reflect degeneration of the frontal and/or temporal lobes. Below is a comprehensive list.

Behavioral Variant FTD (bvFTD)

• Disinhibition: inappropriate jokes, impulsive spending, sexual or socially unacceptable behavior.
• Apathy or loss of motivation: reduced initiative, less interest in hobbies.
• Compulsive or ritualistic behaviors: repetitive cleaning, counting, or hoarding.
• Loss of empathy: difficulty recognizing others’ emotions.
• Changes in eating habits: preference for sweet foods, overeating, or bizarre food choices.
• Executive dysfunction: poor planning, difficulty multitasking, and trouble with problem solving.

Language (Primary Progressive Aphasia) Variants

• Semantic variant (svPPA): gradual loss of word meaning, inability to name objects, fluent but empty speech.
• Non‑fluent/agrammatic variant (nfvPPA): halting speech, effortful articulation, grammar errors, and speech apraxia.
• Pronunciation and reading difficulties: misreading words, spelling errors (dysgraphia).

Motor and Sensory Features (seen in some patients)

• Parkinsonism – stiffness, slowed movements, tremor.
• Upper motor neuron signs – spasticity, hyperreflexia.
• Weakness or loss of coordination (corticobasal syndrome).

General Cognitive Changes

• Short‑term memory may remain relatively intact in early stages, unlike Alzheimer’s disease.
• Difficulties with judgment, insight, and abstract thinking.
• Impaired social cognition – trouble interpreting sarcasm or facial expressions.

Psychiatric Manifestations

• Depression, anxiety, or obsessive‑compulsive symptoms.
• In rare cases, psychosis with delusions or hallucinations.

Causes and Risk Factors

FTD is a heterogeneous disorder with both genetic and sporadic forms.

Genetic Causes

• Mutations in MAPT (microtubule‑associated protein tau): ~30 % of familial FTD.
• GRN (progranulin) mutations: ~25 % of familial cases.
• C9orf72 hexanucleotide repeat expansion: the most common cause of hereditary FTD and amyotrophic lateral sclerosis (ALS) overlap.
• Less common genes: VCP, TBK1, CHMP2B, and others.

When a first‑degree relative has FTD or ALS, the lifetime risk of developing FTD rises to **~30–40 %**.^[3]

Non‑Genetic (Sporadic) Factors

• Age: most diagnoses occur between 45‑65 years.
• Sex: slight male predominance in bvFTD; language variants are more evenly distributed.
• Environmental exposures (e.g., head trauma, occupational toxins) have been investigated, but clear causal links are lacking.

Risk Factors Summary

• Family history of FTD or ALS.
• Known pathogenic genetic mutation.
• Age >45 years (early onset).
• Possible contributors: traumatic brain injury, exposure to certain metals, but evidence is modest.

Diagnosis

Diagnosing FTD is challenging because symptoms overlap with psychiatric disorders and other dementias. A multidisciplinary approach is essential.

Clinical Evaluation

• Detailed history focusing on behavioral changes, language decline, and functional loss.
• Neuropsychological testing to assess executive function, language, and social cognition.
• Physical and neurological examinations to identify motor signs.

Neuroimaging

• MRI: shows frontal and/or anterior temporal atrophy; patterns differ by variant.
• FDG‑PET: reduced glucose metabolism in affected lobes; helpful when MRI is equivocal.
• DaTscan (SPECT): can differentiate FTD from Parkinsonian syndromes.

Biomarkers

• CSF tau and β‑amyloid ratios are typically normal in FTD (unlike Alzheimer’s disease).
• Blood or CSF neurofilament light chain (NfL) may be elevated and correlates with disease severity.

Genetic Testing

Recommended when:

• There is a family history of FTD/ALS.
• Patients present before age 55.
• Patients request testing after counseling.

Diagnostic Criteria

International consensus criteria (Neary 1998; Rascovsky 2011 for bvFTD) provide a structured algorithm based on clinical features, imaging, and exclusion of other causes.

Treatment Options

There is currently **no cure** for FTD, and disease‑modifying therapies are under investigation. Management focuses on symptom control, supportive care, and maintaining quality of life.

Pharmacologic Therapies

• Selective serotonin reuptake inhibitors (SSRIs): sertraline, fluoxetine, or citalopram can reduce disinhibition, compulsive behaviors, and anxiety.
• Antipsychotics: low‑dose atypicals (e.g., quetiapine) may be used for severe agitation or psychosis, but carry a risk of sedation and metabolic side effects.
• Cholinesterase inhibitors (donepezil, rivastigmine): generally ineffective for FTD and may worsen behavior; not routinely recommended.
• Memantine: limited evidence; sometimes tried in mixed dementia cases.
• Targeted therapies (research): antisense oligonucleotides for C9orf72, tau‑targeting antibodies, and progranulin‑enhancing agents are in clinical trials.

Non‑Pharmacologic Interventions

• Speech‑language therapy: aids communication in language variants.
• Behavioral interventions: structured routines, positive reinforcement, and environmental modifications reduce problematic behaviors.
• Physical & occupational therapy: maintain mobility, balance, and activities of daily living (ADLs).
• Caregiver education & support groups: essential for managing stress and preventing burnout.

Procedural Options

• None are disease‑specific. However, feeding tube placement may become necessary if dysphagia progresses.
• Advanced care planning (e.g., legal directives, power of attorney) should be addressed early.

Living with Frontotemporal Dementia

Living with FTD requires adaptation for both the person affected and their support network.

Daily Management Tips

• Maintain a predictable routine: Consistent schedules reduce confusion and anxiety.
• Simplify the environment: Reduce clutter, use clear signage, and keep essential items in the same place.
• Use visual cues: Labels, color‑coded bins, and picture schedules help with task initiation.
• Encourage safe social interaction: Small, familiar groups are often better tolerated than large gatherings.
• Monitor nutrition and hydration: Offer small, frequent meals, especially if appetite changes.
• Promote physical activity: Walking, seated exercises, or yoga improve mood and preserve motor function.
• Plan for communication: Augmentative devices, picture boards, or texting can aid language‑variant patients.
• Legal/financial preparation: Early discussions about wills, powers of attorney, and insurance are crucial while decision‑making capacity remains.

Caregiver Support

• Join national organizations (e.g., Frontotemporal Dementia Support Group, Alzheimer’s Association) for resources.
• Utilize respite care services to prevent burnout.
• Consider counseling or psychotherapy to manage stress and grief.

Prevention

Because many cases are genetically driven, true primary prevention is limited. Nonetheless, adopting a brain‑healthy lifestyle may lower overall dementia risk.

• Cardiovascular health: Control hypertension, diabetes, and cholesterol.
• Regular exercise: At least 150 minutes of moderate aerobic activity per week.
• Balanced diet: Mediterranean or DASH diet rich in fruits, vegetables, fish, and healthy fats.
• Avoid smoking and limit alcohol.
• Cognitive stimulation: Learning new skills, reading, or playing music.
• Protect against head injury: Wear helmets, use seatbelts, and treat concussions promptly.

For individuals with a known pathogenic mutation, participation in research trials may provide early‑stage interventions as they become available.

Complications

If left unmanaged, FTD can lead to serious medical and social complications.

• Severe behavioral disturbances: aggression, wandering, or self‑neglect may require institutional care.
• Malnutrition and dehydration: due to loss of appetite, dysphagia, or forgetting to eat.
• Falls and fractures: motor impairment and poor judgment increase risk.
• Aspiration pneumonia: common when swallowing is compromised.
• Social isolation and caregiver burnout: leading to depression or anxiety in both patient and family.
• Legal and financial crises: poor judgment may result in financial exploitation.

When to Seek Emergency Care

References

1. Mayo Clinic. “Frontotemporal dementia.” Updated 2023. https://www.mayoclinic.org
2. Alzheimer’s Association. “Statistics on Frontotemporal Dementia.” 2022. https://www.alz.org
3. Van Langenhove T, et al. “Genetic frontotemporal dementia.” *Lancet Neurology* 2021;20(12):1029‑1040. doi:10.1016/S1474-4422(21)00197-5
4. Rascovsky K, et al. “Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.” *Brain* 2011;134:2456‑2477. doi:10.1093/brain/awr179
5. National Institute on Aging. “Frontotemporal Dementia Fact Sheet.” 2024. https://www.nia.nih.gov